Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis
Open accessThe DOI matches its Crossref record; 68 of the 69 references it cites were found in a registry or an index; 36 of the 74 sources its claims cite were checked for support.
Abstract
Despite its abundance in the environment, iron is poorly bioavailable and subject to strict conservation and internal recycling by most organisms. In vertebrates, the stability of iron concentration in plasma and extracellular fluid, and the total body iron content are maintained by the interaction of the iron-regulatory peptide hormone hepcidin with its receptor and cellular iron exporter ferroportin (SLC40a1). Ferroportin exports iron from duodenal enterocytes that absorb dietary iron, from iron-recycling macrophages in the spleen and the liver, and from iron-storing hepatocytes. Hepcidin blocks iron export through ferroportin, causing hypoferremia. During iron deficiency or after hemorrhage, hepcidin decreases to allow iron delivery to plasma through ferroportin, thus promoting compensatory erythropoiesis. As a host defense mediator, hepcidin increases in response to infection and inflammation, blocking iron delivery through ferroportin to blood plasma, thus limiting iron availability to invading microbes. Genetic diseases that decrease hepcidin synthesis or disrupt hepcidin binding to ferroportin cause the iron overload disorder hereditary hemochromatosis. The opposite phenotype, iron restriction or iron deficiency, can result from genetic or inflammatory overproduction of hepcidin.
Overview
CoChat Summary
TL;DR
The review describes how hepcidin binding to ferroportin controls systemic iron homeostasis by blocking cellular iron export, thereby regulating plasma iron, erythropoiesis, and host defense. Dysregulation of this axis causes iron overload such as hereditary hemochromatosis or iron-restrictive anemias, making it a therapeutic target.
Key findings
- Hepcidin, a 25-amino-acid peptide (MW 2.8 kD) present at approximately 2–20 nM in healthy humans, binds ferroportin (SLC40A1; 571 amino acids, ~65–70 kD) and inhibits iron export by occluding the open-outward conformation and inducing endocytosis/degradation.
- Ferroportin exports iron from duodenal enterocytes, iron-recycling macrophages, and hepatocytes; adult humans have total body iron of approximately 3–4 g with daily losses of only 1–2 mg, while plasma transferrin holds only 2–3 mg of iron but delivers 20–25 mg/day.
- The erythron contains approximately 2–3 g of iron, about 2/3–3/4 of total body iron; hepatocyte stores contain up to 1 g, the spleen normally about 0.05 g, and other tissues about 0.3 g.
- Loss of hepcidin or disrupted hepcidin binding to ferroportin causes hereditary hemochromatosis; excessive hepcidin, such as from TMPRSS6 mutations, causes iron-refractory iron deficiency anemia (IRIDA), and inflammatory hepcidin increases produce hypoferremia and nutritional immunity.
Methods
- Narrative review synthesizing published literature; no primary experimental design, sample, or statistical analysis is reported.
- The text integrates structural, genetic, physiological, and clinical evidence from cited studies, including mouse models and human disease examples.
- Not stated in the paper: systematic search strategy, inclusion/exclusion criteria, or data-extraction methods.
Limitations
- The paper states unresolved issues: how ferroportin’s two divalent metal-binding sites mediate export is not clear; the energetics of iron export are not well characterized; functional consequences of tissue-specific ferroportin glycosylation are not understood; the quantitative contribution of hepcidin clearance mechanisms is unknown; and the physiological role of microRNA regulation is uncertain.
- Evident from the text: as a narrative review, it lacks a described systematic search or formal quality assessment, so conclusions depend on selected cited literature.
- Not stated in the paper: an explicit limitations section or discussion of publication bias.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures


![Figure 3 A current model of hepcidin (orange) interaction with ferroportin (blue) in which binding is dependent on iron (green). The framework of helices that make up ferroportin are depicted as cylinders connected by extracellular and intracellular disordered loops. The side chains that make up the binding sites for iron are shown. Modified from [14].](https://figures.cochat.ai/paper-figures/a8d0b48e97e349ad9b7b164106596b50/hepcidin-ferroportin-interaction-controls-systemic-iron-homeostasis-figure-3.jpg)


Verification
Claims the paper makes
31 Valid · 2 Not valid · 28 Not checked · 21 Own results and interpretations
At least one cited source doesn’t support this claim or points to a different paper, and none confirmed it — see the verdicts below.
In the paper
“Because iron is exported against the force exerted by the transmembrane electric field, and there is no evidence of direct coupling of the transport to ATP hydrolysis, the export of iron is likely facilitated by the coupled “downhill” transport of another ion or small molecule [13].”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 4. Ferroportin Structure
What the sources say
- Disputedcites [13] Deshpande, 2018, Calcium is an essential cofactor for metal efflux by the ferroportin transporter family, Nat. Commun. sourceExperimental — accuracy not yet measured
The Results section reports that iron efflux does not depend on a transmembrane H+ gradient or Na+, and experiments do not support Fe2+/Ca2+ antiport. The paper instead identifies extracellular Ca2+ as a cofactor that activates ferroportin without being transported. These findings run contrary to the proposed downhill-coupled transport mechanism. (LLM, conf=0.84)
Checked by a reasoning model — may be wrong.
hedgedstates a possible cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 2 assumptions not shown here.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Efficient filtration of hepcidin in the glomerulus is facilitated by the relatively low fraction of hepcidin that is bound by plasma protein, estimated at about 40% [28].”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 6. Hepcidin Synthesis and Elimination
What the sources say
- Partly supportedcites [28] Diepeveen, L.E., Laarakkers, C.M., Peters, H.P.E., van Herwaarden, A.E., Groenewoud, H., IntHout, J., Wetzels, J.F., van Swelm, R.P.L., and Swinkels, D.W. (2019). Unraveling hepcidin plasma protein binding: Evidence from peritoneal equilibration testing. Pharmaceuticals, 12. sourceExperimental — accuracy not yet measured
The Abstract reports a hepcidin protein-bound fraction of 40% (±23%), and the Discussion says hepcidin is not predominantly bound and is rapidly excreted by the kidneys. The study used peritoneal dialysis in patients with end-stage renal disease; it does not establish that low protein binding facilitates efficient filtration in the glomerulus. (LLM, conf=0.86)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“A recent study [21] provide convincing evidence that Rnf217 is an important E3 ubiquitin ligase that triggers the degradation of ferroportin in response to hepcidin binding.”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 5. Ferroportin Interactions with Hepcidin
What the sources say
- Supportedcites [21] Jiang, L., Wang, J., Wang, K., Wang, H., Wu, Q., Yang, C., Yu, Y., Ni, P., Zhong, Y., and Song, Z. (2021). RNF217 regulates iron homeostasis through its E3 ubiquitin ligase activity by modulating ferroportin degradation. Blood. source
The Introduction states that hepcidin binds ferroportin and induces its internalization and degradation. The Results report that RNF217’s E3 ubiquitin ligase activity is required for ferroportin degradation and that hepcidin-mediated degradation is at least partially RNF217-dependent in mice. The paper also notes that RNF217 can promote degradation without added hepcidin in vitro, so the response to hepcidin is not its only observed mode of action. (LLM, conf=0.91)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Moreover, duodenal iron absorption increases several-fold after blood loss or exposure to hypoxia, or in response to iron deficiency.”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 2. Iron Compartments and Flows
What the sources say
- Partly supportedcites [3] Finch, 1994, Regulators of iron balance in humans, Blood sourceExperimental — accuracy not yet measured
The Store Regulator (p. 2) says absorption is high when iron stores are depleted, and The Erythroid-Regulator (p. 3) reports increased absorption after phlebotomy and in iron-deficiency anemia. The latter section links hypoxia to erythropoietin release, but does not report a several-fold rise in duodenal absorption after hypoxia exposure; it also does not establish a several-fold increase for each condition in the claim. (LLM, conf=0.84)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The model also revealed an important unexpected feature, the indication that the suspected hepcidin-binding site in the C-lobe, centered on the critically important C325 thiol cysteine, utilizes an iron atom to coordinate hepcidin binding [14].”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 5. Ferroportin Interactions with Hepcidin
What the sources say
- Partly supportedcites [14] Billesbolle, 2020, Structure of hepcidin-bound ferroportin reveals iron homeostatic mechanisms, Nature sourceExperimental — accuracy not yet measured
The hepcidin-binding section (p. 6) supports the role of a C-domain metal site: iron greatly increases hepcidin affinity, and mutations at that site weaken binding. But the cited paper identifies the coordinating cysteine as C326, not C325; C325 is not the cysteine named in this claim. The structure directly shows cobalt, an iron mimetic, at the site. (LLM, conf=0.92)
hedgedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
44 more claims · 19 with their cited sources checked
Create a free account to see all 82 claims and to verify the 10 references still open.
- It may state two separate claims as one. 31
- Probably not a substantial claim. 3
- The quote only partly states this claim. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 5. Ferroportin Interactions with Hepcidin
“the suspected hepcidin-binding site in the C-lobe, centered on the critically important C325 thiol cysteine”
§ Hepcidin-Ferroportin Interaction Controls Systemic Iron Homeostasis > 7. Evidence for Exclusivity of the Hepcidin-Ferroportin Ligand-Receptor Dyad
“the essential conserved amino acid at the ferroportin binding site for hepcidin, C326 (human numbering)”
Citations
Cites
Targeting Hypoxia-Inducible Factors for the Treatment of Anemia in Chronic Kidney Disease Patients
Locatelli, F., Fishbane, S., Block, G. A., & Macdougall, I. C. (2017) · American Journal of Nephrology · doi:10.1159/000455166 · Cited by 4,813
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803 · cited 3×
“The flow of iron out of the cells is controlled by hepcidin through two known mechanisms: occlusion of the open-outward conformation of ferroportin by hepcidin [17], and hepcidin-induced endocytosis and degradation of ferroportin [4].”
BackgroundSelf-citationNemeth, E., Rivera, S., Gabayan, V., Keller, C., Taudorf, S., Pedersen, B. K., & Ganz, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420945 · Cited by 2,650 · cited 2×
“Infection and inflammation induce hepcidin, predominantly through the effects of the cytokine interleukin-6 (IL-6) [52], and increased concentrations of hepcidin then inhibit ferroportin activity, leading to depletion of iron in plasma and extracellular fluid (hypoferremia).”
BackgroundSelf-citationHepcidin, a urinary antimicrobial peptide synthesized in the liver
Park, C. H., Valore, E. V., Waring, A. J., & Ganz, T. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008922200 · Cited by 2,168 · cited 1×
“Hepcidin can also kill microbes on contact in vitro [59,60] but the concentrations required for this direct microbicidal activity exceeded its concentrations in extracellular fluid, even in inflamed models.”
BackgroundSelf-citationPositional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter
Donovan, A., Brownlie, A., Zhou, Y., Shepard, J., Pratt, S. J., Moynihan, J., Paw, B. H., Drejer, A., Barut, B., Zapata, A., et al. (2000) · Nature · doi:10.1038/35001596 · Cited by 1,667 · cited 1×
“During pregnancy, ferroportin is very highly expressed on the basal surface of syncytiotrophoblast in the placenta [7,50], where it plays an indispensable role in iron transfer to the fetus.”
BackgroundMcKie, A. T., Marciani, P., Rolfs, A., Brennan, K., Wehr, K., Barrow, D., Miret, S., Bomford, A., Peters, T. J., Farzaneh, F., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80425-6 · Cited by 1,422
Zimmermann, M. B., & Hurrell, R. F. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61235-5 · Cited by 1,405 · cited 1×
“Iron deficiency, iron deficiency anemia [65] and anemia of inflammation [66] are very common disorders affecting a large portion of the population.”
BackgroundDysmetabolic Hyperferritinemia: All Iron Overload Is Not Hemochromatosis
Makker, J., Hanif, A., Bajantri, B., & Chilimuri, S. (2015) · Case Reports in Gastroenterology · doi:10.1159/000373883 · Cited by 1,351
LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity
Krause, A., Neitz, S., Mägert, H.-J., Schulz, A., Forssmann, W.-G., Schulz-Knappe, P., & Adermann, K. (2000) · FEBS Letters · doi:10.1016/s0014-5793(00)01920-7 · Cited by 1,324 · cited 1×
“Hepcidin can also kill microbes on contact in vitro [59,60] but the concentrations required for this direct microbicidal activity exceeded its concentrations in extracellular fluid, even in inflamed models.”
BackgroundA Novel Mammalian Iron-regulated Protein Involved in Intracellular Iron Metabolism
Abboud, S., & Haile, D. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000713200 · Cited by 1,267
Cited by
Items 101–200 of 530
He, J., Du, C., Li, C., Li, W., Qiu, J., Ma, M., Chen, Y., & Zhang, Q. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103657 · Cited by 26
Distinctive modulation of hepcidin in cancer and its therapeutic relevance
Lin, F., Tuffour, A., Hao, G., Addai, F. P., Huang, A., Zhou, Y., & Zhang, H. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1141603 · Cited by 20
“It is an advanced liver disease and one of the leading causes of cancer-related deaths (72).”
BackgroundAdamyan, L. V., Pivazyan, L. G., & Mailova, K. S. (2023) · Russian Journal of Human Reproduction · doi:10.17116/repro20232905192 · Cited by 19
Zaugg, J., López‐Tello, J., Musiał, B., Vaughan, O. R., Fowden, A. L., Albrecht, C., & Sferruzzi-Perri, A. N. (2024) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-024-05192-5 · Cited by 25
Maio, N., Saneto, R. P., Steet, R., de Menezes, M. A. S., Skinner, C. D., & Rouault, T. A. (2022) · Brain Communications · doi:10.1093/braincomms/fcac102 · Cited by 22
Zhang, J., Chen, X., Huang, D., & Tan, X. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2024.114002 · Cited by 18
Wang, J., Shi, H., Yang, Y. S., & Gong, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1505794 · Cited by 30
“Exocytosis of intracellular iron, reliant on FPN1, also known as solute carrier family 40 member 1 (SLC40A1), is the only mechanism capable of transporting non-heme iron out of the cell (33).”
Wang, M., Xiao, W., Feng, Z., Choubey, M., Chen, S., Pan, R., Gong, K., Tirumalasetty, M. B., Gao, F., Liao, C., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-61067-8 · Cited by 24
“Hepcidin expression downregulation can increase intestinal iron absorption and iron release from its physiologic supplies by upregulating divalent metal transporter 1 (DMT1) and ferro-protein (FPN) expression 22 .”
Molecular Mechanisms of Iron Metabolism and Overload
Tayal, A., Kaur, J., Sadeghi, P., & Maitta, R. W. (2025) · Biomedicines · doi:10.3390/biomedicines13092067 · Cited by 31
“FPN (SLC40A1) is critical for exporting iron from cells involved in storage and recycling, such as enterocytes, macrophages, and hepatocytes [78].”
Repositioning Antimicrobial Peptides Against WHO‐Priority Fungi
Roque‐Borda, C. A., Medina‐Alarcón, K. P., Pereira, J. P. S. G., Sevilhano, T. C. D. A., Aguilar‐Morón, B., Díaz‐Cárdenas, F., da Cruz, L. S., Júnior, F. H. X., Vicente, E. F., Perdigão, J., et al. (2025) · Advanced Science · doi:10.1002/advs.202509567 · Cited by 24
Targeting ferroptosis as a therapeutic strategy for hepatotoxicity
Hemmati, N., Anoush, M., Kiasari, B. A., & Torkamani, A. (2025) · Toxicology Reports · doi:10.1016/j.toxrep.2025.102137 · Cited by 25
“Hepcidin strictly controls the amount of iron in the plasma by binding to ferroportin, the only known cellular iron exporter [82, 83].”
Translational Control of Metabolism and Cell Cycle Progression in Hepatocellular Carcinoma
Scagliola, A., Miluzio, A., & Biffo, S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24054885 · Cited by 21
“The liver’s contribution to the blood includes the regulated secretion of hormones such as hepcidin, which is necessary for iron metabolism [5], and thrombopoietin [6], in conjunction with the kidneys, which stimulates platelet generation, as well as others.”
BackgroundHepcidin's Antimalarial Arsenal: Safeguarding the Host
Obeagu, E. I., Alum, E. U., & Ugwu, O. P.-C. (2023) · NEWPORT INTERNATIONAL JOURNAL OF PUBLIC HEALTH AND PHARMACY · doi:10.59298/nijpp/2023/10.1.1100 · Cited by 30
Cross-talk between biometal ions and immune cells for bone repair
Liu, S., Lin, Z., Qiao, W., Chen, B., & Shen, J. (2024) · Engineered Regeneration · doi:10.1016/j.engreg.2024.01.003 · Cited by 29
The relation between BTK expression and iron accumulation of myeloid cells in multiple sclerosis
Steinmaurer, A., Riedl, C. J., König, T., Testa, G., Köck, U., Bauer, J., Lassmann, H., Höftberger, R., Berger, T., Wimmer, I., et al. (2024) · Brain Pathology · doi:10.1111/bpa.13240 · Cited by 18
“Hepcidin acts as a functional antagonist of the cellular iron exporter ferroportin (FPN), thus mediating myeloid cell iron retention, particularly under proinflammatory conditions [24].”
BackgroundSato, R., Koziolek, M. J., & von Haehling, S. (2024) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2024.10.024 · Cited by 19
Fisher, A. L., Phillips, S., Wang, C., Paulo, J. A., Xiao, X., Xu, Y., Moschetta, G. A., Xue, Y., Mancias, J. D., & Babitt, J. L. (2024) · Blood · doi:10.1182/blood.2024024795 · Cited by 20
Chen, Q., Wang, J., Li, N., Cai, H., & Lu, Y.-Y. (2025) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2025.104924 · Cited by 19
Crosstalk Between Intestinal Microbiota and Host Defense Peptides in Fish
Yu, X., Yu, Y., & Liu, Z. (2025) · Biology · doi:10.3390/biology14091243 · Cited by 22
“The mature peptide of HAMP1 features an iron-regulatory sequence (Q-S-H/N-L/I-S) at its N-terminus, which plays a critical role in iron transport and regulation, whereas this motif is absent in HAMP2, suggesting functional divergence [61,62].”
Excess iron aggravates the severity of COVID-19 infection
Chaubey, G. K., Dilawari, R., Modanwal, R., Talukdar, S., Dhiman, A., Raje, C. I., & Raje, M. (2023) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2023.08.011 · Cited by 17
Chen, K., Wei, X., Zhang, W., Wang, R., Wang, Y., & Yang, L. C. (2024) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2024.05.007 · Cited by 17
“We next investigated the iron status by testing the expression of DMT-1 (a transporter promoting iron intake (Urrutia et al., 2013), FPN (the only known iron exporter (Nemeth and Ganz, 2021) and ferritin (the cellular iron form (Ueda and Takasawa, 2018).”
Chatzikalil, E., Arvanitakis, K., Kalopitas, G., Florentin, M., Germanidis, G. S., Koufakis, T., & Solomou, E. E. (2025) · Cancers · doi:10.3390/cancers17030392 · Cited by 17
“The normal range of serum hepcidin in the human body is between 2 and 20 nm, while hepcidin expression is mostly elevated in many types of cancer, including prostate cancer, multiple myeloma, breast cancer, and non-lymphoma Hodgkin’s disease [158,159].”
Neuronal Injury after Ischemic Stroke: Mechanisms of Crosstalk Involving Necroptosis
Zhang, X. Y., Li, H., Zhao, Y., Zhao, T., Wang, Z., & Tang, Q. (2025) · Journal of Molecular Neuroscience · doi:10.1007/s12031-025-02313-y · Cited by 21
“The upregulation of hepcidin limits the release of iron into the bloodstream by inhibiting FPN1, which consequently increases intracellular iron levels(Nemeth and Ganz 2021; P. Wang et al. 2021a, b).”
Independent somatic distribution of heme and iron in ticks
Perner, J., Hajdušek, O., & Kopáček, P. (2022) · Current Opinion in Insect Science · doi:10.1016/j.cois.2022.100916 · Cited by 16
Xu, Q., Li, Z., Zhang, Y., Wu, M., Shen, A., Tang, T.-T., Li, N., Zhang, Y., Xue, D.-D., Fu, Y., et al. (2025) · Kidney International · doi:10.1016/j.kint.2025.05.030 · Cited by 16
Iron Deficiency in Cystic Fibrosis: A Cross-Sectional Single-Centre Study in a Referral Adult Centre
Lobbes, H., Durupt, S., Mainbourg, S., Pereira, B., NOVE-JOSSERAND, R., Durieu, I., & Reynaud, Q. (2022) · Nutrients · doi:10.3390/nu14030673 · Cited by 15
“Inflammation leads to an increase in ferritin levels due to the enhanced hepcidin production through the effects of interleukin-6 [12].”
BackgroundFischer, C., de Souza, L. V., Komlódi, T., Garcia-Souza, L. F., Volani, C., Tymoszuk, P., Demetz, E., Seifert, M., Auer, K., Hilbe, R., et al. (2022) · Metabolites · doi:10.3390/metabo12030270 · Cited by 18
“Iron metabolism is tightly regulated by the liver-derived peptide hormone hepcidin, which mediates the degradation of ferroportin, the only cellular iron exporter known so far, thereby controlling iron absorption and iron recycling from macrophages [13].”
BackgroundIron deficiency and iron deficiency anemia in general medical practice
Polyakova, O. A., Клепикова, М. В., Litvinova, S. N., Isaakyan, Y. A. I., & Ostroumova, O. D. (2022) · Russian Journal of Preventive Medicine · doi:10.17116/profmed202225121127 · Cited by 16
Yan, P., Li, N., Ma, M., Liu, Z., Yang, H., Li, J., Wan, C., Gao, S., Li, S., Zheng, L. T., et al. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01578-2 · Cited by 18
Zhang, X., Sun, J., Wang, J., Meng, T., Yang, J., & Zhou, Y. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1286718 · Cited by 17
“Recent studies have shown that FPN is also present in cardiomyocytes.”
BackgroundInfluentialTziastoudi, M., Pissas, G., Golfinopoulos, S., Filippidis, G., Dousdampanis, P., Eleftheriadis, T., & Stefanidis, I. (2023) · Life · doi:10.3390/life13122338 · Cited by 21
“In instances of in vivo iron deficiency, decreased hepcidin expression allows iron to be released into the plasma via FPN [51].”
BackgroundNovikov, N. D., Buch, A., Yang, H. J., Andruk, M., Liu, G., Wu, M., Howell, H., MacDonald, B., & Savage, W. (2024) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.2432 · Cited by 19
“19,20 Hepcidin binds the iron transporter ferroportin, leading to ubiquitination and degradation.”
Guo, W., Zhang, J., Zhang, X., Ren, Q., Zheng, G., Zhang, J., & Nie, G. (2024) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2024.116246 · Cited by 19
Wang, Y., Li, X., Qu, T., Huang, F., Xu, J., Gao, H., & Zhang, S. (2024) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2024.173118 · Cited by 15
Khazaei, M., & Ardeshir, R. A. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.117715 · Cited by 15
Moreira, A. C., Silva, T., Mesquita, G., Gomes, A. C., Bento, C. M., Neves, J. V., Rodrigues, D. F., Rodrigues, P., Almeida, A. A., Santambrogio, P., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010269 · Cited by 19
“On the other hand, FTH1 expression modulates macrophage activation by immune and microbial stimuli and is essential for cell protection against oxidative stress [3,17], suggesting that FTH1 contributes to host defense against infection.”
BackgroundVitamin E Induces Liver Iron Depletion and Alters Iron Regulation in Mice
Baratz, E., Protchenko, O. V., Jadhav, S., Zhang, D., Violet, P.-C., Grounds, S., Shakoury‐Elizeh, M., Levine, M., & Philpott, C. C. (2023) · Journal of Nutrition · doi:10.1016/j.tjnut.2023.04.018 · Cited by 13
Differences in DNA methylation of HAMP in blood cells predicts the development of type 2 diabetes
Ouni, M., Eichelmann, F., Jähnert, M., Krause, C., Saussenthaler, S., Ott, C., Gottmann, P., Speckmann, T., Huypens, P., Wolter, S., et al. (2023) · Molecular Metabolism · doi:10.1016/j.molmet.2023.101774 · Cited by 14
“In the state of iron deficiency, hepcidin levels decrease allowing iron delivery to the plasma [40,41].”
BackgroundExploring the impact of estrogen-related receptor gamma on metabolism and disease
Sadasivam, N., Park, W., Choi, B., Jung, Y. S., Choi, H., & Kim, D. (2024) · Steroids · doi:10.1016/j.steroids.2024.109500 · Cited by 16
Wang, M., Zheng, C., Zhou, F., Xie, Y., Zhang, X., Peng, C., & Wang, L. (2024) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16826 · Cited by 14
Okazaki, Y. (2022) · Cancers · doi:10.3390/cancers14061495 · Cited by 14
“Oral administration of Fe-NTA did not induce RCC [8], which is consistent with the tight regulation of intestinal iron absorption [9].”
BackgroundBerezovsky, B., Frýdlová, J., Gurieva, I., Rogalsky, D. W., Vokurka, M., & Krijt, J. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23115899 · Cited by 13
“The interaction of hepcidin with ferroportin represents the cornerstone of mammalian iron homeostasis [14], and many studies have demonstrated that decreased hepcidin levels result in increased enterocyte ferroportin content and, as a consequence, iron overload [12,13,15].”
BackgroundInfluentialSłomka, A., Łęcka, M., & Styczyński, J. (2022) · Cancers · doi:10.3390/cancers14194936 · Cited by 13
“Produced by the hepatocytes, this small 25-amino acids protein inhibits iron absorption and releases from tissue resources by degrading ferroportin, the sole known cellular iron exporter [19].”
BackgroundThe metabolic fate of iron-based magnetic nanomaterials and their impact on macrophage function
Huang, Y., Cai, X., Yan, L., Zhang, M., Sheng, J., & Gu, N. (2025) · Magnetic Medicine · doi:10.1016/j.magmed.2025.100002 · Cited by 15
Zhou, F., Li, G., Tan, R., Wu, G., & Deng, C. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70086 · Cited by 16
Ferroptosis in Gastrointestinal Diseases: A New Frontier in Pathogenesis and Therapy
Wawrzeńczyk, A., Napiórkowska-Baran, K., Alska, E., Gruszka-Koselska, A., Szynkiewicz, E., Sławatycki, J., Klemenska, P., & Bartuzi, Z. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14124035 · Cited by 12
“However, further investigation is necessary to assess the safety, pharmacodynamics, and pharmacokinetics of these combinations, and to evaluate their efficacy across diverse patient populations [21].”
Zhang, S., Shen, C., Han, D., Wang, Y., & Guan, F. (2025) · Antioxidants · doi:10.3390/antiox14070760 · Cited by 15
“Iron, a vital trace element, functions as a versatile catalytic cofactor in numerous enzymes involved in a variety of biological reactions and biosynthetic processes [119].”
Iron from the gut: the role of divalent metal transporter 1
Okazaki, Y. (2023) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.23-47 · Cited by 23
“(73) These results indicate that the degree of inflammation and its response may modulate cytokine-induced hepcidin secretion.”
BackgroundSong, J., Chen, Q., Xu, S., Gou, Y., Guo, Y., Jia, C., Zhao, C., Zhang, Z., Li, B., Zhao, Y., et al. (2023) · Current Issues in Molecular Biology · doi:10.3390/cimb45120636 · Cited by 13
“Elevated levels of hepcidin can impede the expression of FPN1 protein, resulting in a reduction in iron release and exacerbating iron deposition [46].”
BackgroundMicronutrient Deficiencies in Older Adults in Latin America: A Narrative Review
la Cruz-Góngora, V. V. D., Palazuelos‐González, R., & Domínguez-Flores, O. (2023) · Food and Nutrition Bulletin · doi:10.1177/03795721231214587 · Cited by 22
“82 Consequently, prolonged iron deprivation (referred to as functional iron deficiency) can lead to anemia of chronic diseases or anemia of inflammation.”
Ferroptosis: A new strategy for targeting Alzheimer’s disease
Qiang, R. R., Xiang, Y., Zhang, L., Bai, X. Y., Zhang, D., Li, Y. J., Yang, Y. L., & Liu, X. L. (2024) · Neurochemistry International · doi:10.1016/j.neuint.2024.105773 · Cited by 17
Dapagliflozin Alleviates High-Fat-Induced Obesity Cardiomyopathy by Inhibiting Ferroptosis
Chen, D., Shi, J., Wu, Y., Miao, L., Wang, Z., Wang, Y., Xu, S., & Lou, Y. (2024) · ESC Heart Failure · doi:10.1002/ehf2.15150 · Cited by 17
“47 When the cellular iron homeostasis is out of balance, it can cause intracellular iron overload and damage mitochondria, proteins and nucleic acids, resulting in cell damage.”
Huang, Y., Yuan, T., Yang, H., Zhang, J., Yan, B., Zhang, H., Chen, W., & Fan, D. (2025) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.4c11535 · Cited by 13
Altered iron metabolism as a target for ferroptosis induction in head and neck cancer
Lee, J., & Roh, J. (2023) · Cellular Oncology · doi:10.1007/s13402-023-00784-y · Cited by 14
Dual role of hepcidin in response to pathogens
Navidifar, T., Meftah, E., Baghsheikhi, H., Kazemzadeh, K., Karimi, H., & Rezaei, N. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107496 · Cited by 16
Iron and atrial fibrillation: A review
Ju, H., Liu, T., Yang, M., Cheng, M., & Wu, G. (2023) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.14678 · Cited by 14
Bai, X., Wang, B., Cui, Y., Tian, S., Zhang, Y., You, L., Chang, Y.-Z., & Gao, G. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-023-03008-0 · Cited by 14
“In the periphery, hepcidin is mainly produced by hepatocytes and secreted into the plasma, inhibiting iron absorption in the intestines and iron release from macrophages and thus decreasing the plasma iron concentration [3].”
BackgroundTumor versus Tumor Cell Targeting in Metal-Based Nanoparticles for Cancer Theranostics
Urbano‐Gámez, J. D., Guzzi, C., Bernal, M., Solivera, J., Martínez-Zubiaurre, I., Caro, C., & García‐Martín, M. L. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105213 · Cited by 14
“In the particular case of iron oxide NPs (IONPs), they can be partially or completely recycled, incorporating the products into normal iron metabolism [57].”
BackgroundFerroptosis: Regulatory mechanisms and potential targets for bone metabolism: A review
Zhang, Y., Hu, K., Shang, Z., Yang, X., & Cao, L. X. (2024) · Medicine · doi:10.1097/md.0000000000039158 · Cited by 16
“[27,28] 3.”
Iron Metabolism and Ferroptosis in Diabetic Kidney Disease
Mu, F., Luo, P., Zhu, Y., Nie, P., Li, B., & Bai, X. (2025) · Cell Biochemistry and Function · doi:10.1002/cbf.70067 · Cited by 16
“Hepcidin, a hormone secreted by the liver, regulates iron homeostasis by two known mechanisms: occluding the open ‐ outward conformation of FPN and inducing FPN endocytosis and degradation [26], which can decrease the iron content in the circulation.”
Iron Deficiency Treatment in Heart Failure—Challenges and Therapeutic Solutions
Anghel, L., Dinu, C. A., Pătraș, D., Ciubară, A., & Chiscop, I. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14092934 · Cited by 15
“Upon binding, hepcidin facilitates the internalization and degradation of ferroportin, hence inhibiting iron efflux from these cells into the plasma [21].”
Multifaceted Marine Peptides and Their Therapeutic Potential
Владимировна, Г. С., & Ovchinnikova, T. V. (2025) · Marine Drugs · doi:10.3390/md23070288 · Cited by 11
“In vertebrate hosts, hepcidin plays an additional role of hormonal iron regulation: it binds to the iron exporter ferroportin on the cell surface, causing its internalization and degradation [46].”
Cichoń, J., Ostapiuk-Karolczuk, J., Cieślicka, M., Dziewiecka, H., Marcinkiewicz, A., Tafil-Klawe, M., Basta, P., Maciejewski, D., & Skarpańska-Stejnborn, A. (2022) · BMC Sports Science, Medicine and Rehabilitation · doi:10.1186/s13102-022-00465-7 · Cited by 10
“This hormone adversely affects the activity of the main iron export protein, ferroportin, which leads to a decrease of iron absorption in the intestine, and inhibition of iron release from hemolyzed red blood cells and internal organs that store iron [24].”
BackgroundPérez-Peiró, M., Alvarado, M., Martín‐Ontiyuelo, C., Durán, X., Rodriguez, D. A., & Barreiro, E. (2022) · Nutrients · doi:10.3390/nu14193929 · Cited by 13
Pai, A. B., Digigow, R. G., Flühmann, B., & Wacker, M. G. (2023) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2023.04.025 · Cited by 12
Qiu, Z., Yan, B., Zhao, R., Xu, D., Shen, K., Deng, X., & Lu, S. (2021) · Clinica Chimica Acta · doi:10.1016/j.cca.2021.08.029 · Cited by 12
Iron in Porphyrias: Friend or Foe?
Buzzetti, E., Ventura, P., & Corradini, E. (2022) · Diagnostics · doi:10.3390/diagnostics12020272 · Cited by 18
“Hepcidin (coded by the HAMP gene) is a small peptide, mainly synthesized in the hepatocytes; it is released into the circulation and binds to Fpn at the surface of several cells, including enterocytes, macrophages and hepatocytes, leading to its ubiquitination, internalization and lysosomal degradation [18].”
BackgroundQatato, M., Bonadonna, M., Palais, G., Ertl, A., Schmidt, G., Polycarpou‐Schwarz, M., Karim, Z., & Galy, B. (2022) · HemaSphere · doi:10.1097/hs9.0000000000000693 · Cited by 12
Wang, H., Sun, J., Luo, Y., Li, X., & Li, J. (2025) · Renal Failure · doi:10.1080/0886022x.2025.2536732 · Cited by 14
“…of exporting iron ions and ferritin from the cell, respectively, thereby reducing intracellular iron load and enhancing resistance to ferroptosis [9,10]. the overexpression of fPN-1 inhibits celecoxib-and lapatinib-induced ferroptosis by promoting iron export, whereas the knockdown of fPN-1…”
Latunde-Dada, G. O. (2024) · Nutrients · doi:10.3390/nu16020206 · Cited by 12
“This causes reduced iron absorption, since ferroportin, the iron efflux protein, is ubiquitinated by hepcidin [10].”
BackgroundZhen, C., Wang, S., Yang, J., Zhang, G., Cai, C., Wang, J., Wang, A., Xu, Y., Fang, Y., Wei, M., et al. (2025) · Journal of Orthopaedic Translation · doi:10.1016/j.jot.2024.10.012 · Cited by 10
“Once the expression of HAMP is inhibited, the dysfunction of FPN leads to the abnormal function of iron efflux, which will lead to the disorder of iron metabolism in the body [25].”
Srinivasamurthy, S. K., Mittal, P., Goyal, A., Ballal, S., Maharana, L., Goyal, K., Rana, M., Ali, H., Oliver, B. G. G., Paudel, K. R., et al. (2025) · Journal of Trace Elements in Medicine and Biology · doi:10.1016/j.jtemb.2025.127766 · Cited by 14
Nutritional aspects of inflammatory bowel disease
Rimon, R. M., Day, A. S., & Shaoul, R. R. (2023) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2023.2231340 · Cited by 12
“Consequently, in the presence of inflammation, hepcidin levels rise, and iron absorption is inhibited [59].”
BackgroundOkazaki, Y. (2021) · Pathology International · doi:10.1111/pin.13196 · Cited by 12
“All of these mutated genes cause HH by loss of function, while ferroportin, which is known as iron exporter (SLC40A1) and degraded with internalization by hepcidin, causes HH by gain of function to deposit iron in the liver, heart and endocrine organs or loss of function in splenic macrophages, respectively.(87) Howev…”
BackgroundAlarcón‐Yaquetto, D. E., Figueroa-Mujica, R., Valverde-Bruffau, V. J., Vásquez‐Velásquez, C., Sánchez-Huamán, J. J., Jimenez-Troncoso, L., Rozas-Gamarra, R. E., & Gonzales, G. F. (2022) · Physiologia · doi:10.3390/physiologia2010001 · Cited by 10
“After altitude adjustment, no subject had IDA measured by TBI, whereas 14.3% had a TFR-F index > 2 compatible with ID. Low MCV, MCH, and MCV+MCH were observed in 14.3%, 19%, and 14.3% of the cases, respectively.”
BackgroundInfluentialFerritinophagy-mediated iron competition in RUTIs: Tug-of-war between UPEC and host
Gao, M., Zhao, T., Zhang, C., Li, P., Wang, J., Han, J., Zhang, N., Pang, B., & Liu, S. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.114859 · Cited by 11
Traumatic brain injury-related ferroptosis: current perspectives
Zhu, R., Pan, J., Min, Y., Wang, H., Zhang, J., & Liu, F. (2025) · Journal of Molecular Medicine · doi:10.1007/s00109-025-02620-2 · Cited by 12
“Hepcidin, a peptide hormone synthesized by the liver, maintains systemic iron homeostasis by regulating the expression of ferritin and TfR1 [16].”
Tomosugi, N., Koshino, Y., Ogawa, C., Maeda, K., Shimada, N., Tomita, K., Daimon, S., Shikano, T., Ryu, K., Takatani, T., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241813779 · Cited by 10
“Similar phenomena may also be observed in hepatocytes and macrophages, which bear FPN on membranes [19].”
BackgroundCourbon, G., & David, V. (2024) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000995 · Cited by 11
“Indeed, in response to inflammation, several cytokines such as interleukin (IL)-6 stimulate bone leading to its internalization, preventing iron intake from enterocytes and iron release from the retic-ulo-endothelial system [3–5].”
BackgroundLack of Hfe and TfR2 in Macrophages Impairs Iron Metabolism in the Spleen and the Bone Marrow
Comità, S., Falco, P., Mezzanotte, M., Spasić, M. V., & Roetto, A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25179142 · Cited by 10
“Specifically, Hepc binds the iron exporter Ferroportin 1 (Fpn1), triggering Fpn1 internalization and its proteolysis and reducing de facto iron export from cells [4,5].”
BackgroundHuang, X., Yang, Y. F., Bai, Y., Yang, S., Chen, B., Zhang, L., Liu, L., Tao, J., Tu, C., Lin, L. W., et al. (2024) · Aquaculture · doi:10.1016/j.aquaculture.2024.741690 · Cited by 11
Nanomaterials targeting iron homeostasis: a promising strategy for cancer treatment
Li, B., Zhang, B., Cheng, Z., Lou, Y., & Chen, S. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1511197 · Cited by 11
“This process ultimately inhibits the ef fl ux of iron into the bloodstream, thereby reducing circulating iron levels and contributing to iron homeostasis regulation (Nemeth and Ganz, 2021).”
The Regulation of Trace Metal Elements in Cancer Ferroptosis
Wang, X., Xue, Y., Chang, L., Zhu, X., Liu, W., & Liang, T. (2025) · Advanced Biology · doi:10.1002/adbi.202400821 · Cited by 11
Reikvam, H., Rolfsnes, M. G., Rolsdorph, L. Å., Sandnes, M., Selheim, F., Hernandez-Valladares, M., & Bruserud, Ø. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26125744 · Cited by 18
Aguree, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178304 · Cited by 15
“At the interface of cellular and systemic iron regulation, ferroportin is the sole identified iron exporter, which is subject to dual control: translational repression via IRPs and post-translational downregulation by the hepatic peptide hormone hepcidin [182].”
Tortuyaux, R., Avila‐Gutierrez, K., Oudart, M., Mazaré, N., Mailly, P., Deschemin, J., Vaulont, S., Escartin, C., & Cohen‐Salmon, M. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15747 · Cited by 13
New Insights into the Physiology of Iron Transport: An Interdisciplinary Approach
Zaugg, J., Pujol‐Giménez, J., Cabra, R. S., Hofstetter, W., Hediger, M. A., & Albrecht, C. (2022) · CHIMIA International Journal for Chemistry · doi:10.2533/chimia.2022.996 · Cited by 12
Słomka, A., Pokrzywa, A., Strzała, D., Kubiaczyk, M., Wesolowska, O., Denkiewicz, K., & Styczyński, J. (2024) · Cancers · doi:10.3390/cancers16020332 · Cited by 11
“One particularly intriguing player is erythroferrone (ERFE), known for its role in inhibiting hepatic hepcidin synthesis [18,19].”
BackgroundHookworm infection as a model for deepen knowledge of iron metabolism and erythropoiesis in anemia
Furtado, L. F. V., Alves, W. P., da Silva, V. J., & Rabelo, É. M. L. (2024) · Cytokine · doi:10.1016/j.cyto.2024.156559 · Cited by 11
Dogan, D. Y., Urzica, E. I., Hornung, I., Kastl, P., Oguama, D., Fette, F., Nguyen, L. H., Rosenbauer, F., Zacharowski, K. D., Klingmüller, U., et al. (2024) · Blood Advances · doi:10.1182/bloodadvances.2023012322 · Cited by 11
Computational Modeling of Macrophage Iron Sequestration during Host Defense against Aspergillus
Adhikari, B., Scindia, Y. M., Vieira, L. S., Ribeiro, H. D. A. L., Masison, J., Yang, N., Fonseca, L. L., Wheeler, M., Knapp, A., Mei, Y., et al. (2022) · mSphere · doi:10.1128/msphere.00074-22 · Cited by 10
“Regulation of iron export from macrophages (as well as duodenal enterocytes), mediated by the hepcidin-ferroportin axis, has been extensively documented in the literature in the context of normal iron homeostasis and during infections (86, 87).”
BackgroundGuan, X., Guan, X., & Zhu, J.-R. (2023) · Journal of Chemotherapy · doi:10.1080/1120009x.2023.2177808 · Cited by 9
“The stability of iron concentrations in extracellular fluid and plasma, as well as the systemic iron content, is maintained through the interaction between hepcidin and its receptors and ferroportin [13].”
BackgroundHepcidin, ferritin and iron homeostasis in pregnant Spanish Purebred mares
Satué, K., Fazio, E., Cravana, C., & Medica, P. (2023) · Theriogenology · doi:10.1016/j.theriogenology.2023.05.008 · Cited by 12
Paying the Iron Price: Liver Iron Homeostasis and Metabolic Disease
Ameka, M., & Hasty, A. H. (2022) · Comprehensive physiology · doi:10.1002/cphy.c210039 · Cited by 18
“Excellent reviews on the regulation of systemic iron metabolism are provided here (81, 149).”
Borges, B. M., Ramos, R., Preite, N. W., Kaminski, V. D. L., de Castro, P. A., Camacho, M. F., Maximo, M. F., Fill, T. P., Calich, V. L. G., Traynor, A. M., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1268959 · Cited by 10
“The repressed expression of Hamp can indicate that there is a lack of iron even for host, because this hormone binds to ferroportin, leading to its internalization and degradation, causing an inhibition of iron ef fl ux (Nemeth et al., 2004; Nemeth and Ganz, 2021).”
Hemochromatosis—How Not to Overlook and Properly Manage “Iron People”—A Review
Szczerbińska, A., Kasztelan‐Szczerbińska, B., Rycyk, A., Kocki, J., & Cichoż‐Lach, H. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13133660 · Cited by 17
“In normal conditions, ferroportin exports iron from the duodenal enterocytes, hepatic and spleen macrophages, and iron-storing liver cells [10].”
BackgroundHoving, V., Donker, A. E., Schols, S. E. M., & Swinkels, D. W. (2025) · British Journal of Haematology · doi:10.1111/bjh.20030 · Cited by 16
“31,32 27 , 33 Higher doses or shorter IRIDA phenotype has been”
Overview of Ferroptosis in Cadmium Toxicity
Zhang, X., Hua, Z., Lu, Z., Wang, B., Wang, P., Zhang, S., Yang, X., & Zhang, C. (2025) · Biological Trace Element Research · doi:10.1007/s12011-025-04832-6 · Cited by 12
Öneç, K., Altun, G., Aytekin, Ş. Ö., Davran, F., & Öneç, B. (2025) · Journal of Clinical Medicine · doi:10.3390/jcm14217789 · Cited by 8
Mansour, G. K., Hajjar, A. W., & Sajid, M. R. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1726337 · Cited by 15
“Hepcidin functions as the master regulator of iron homeostasis through its direct interaction with ferroportin, the ubiquitous cellular iron exporter expressed in duodenal enterocytes, macrophages, and hepatocytes (8).”
Metadata
- Authors
- Nemeth, E., & Ganz, T.
- Affiliations
- University of California, Los Angeles (US)
- Corresponding author
- Ganz, Tomas
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-06-17
- Volume
- 22
- Issue
- 12
- Pages
- 6493
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8235187
- OpenAlex
- W3172506357
- Semantic Scholar
- 8da9eb7ee1579f5db94cd40eca5fde949bb5967c
- Cited by
- 540
- References
- 69
- Citations by year
- 2026: 101 · 2025: 143 · 2024: 107 · 2023: 110 · 2022: 71 · 2021: 7
- FWCI
- 12.91
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- eScholarship (California Digital Library) (submittedVersion, cc-by)
- Funders
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (R01HD096863)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Life Sciences › Neuroscience › Neurology › Neurological diseases and metabolism
- Keywords
- hepcidin, ferroportin, SLC40A1, iron homeostasis, iron export, hypoferremia, compensatory erythropoiesis, iron deficiency, hereditary hemochromatosis, inflammation, infection, iron overload, iron recycling, macrophages, hepatocytes
- MeSH terms
- Ferroportin, Animals, Biological Transport, Disease Susceptibility, Homeostasis, Humans, Iron, Ligands, Protein Binding, Tissue Distribution, Signal Transduction, Autocrine Communication, Paracrine Communication, Cation Transport Proteins, Metabolic Networks and Pathways, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.